Market open

GRAIL/GRAL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About GRAIL

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.

Ticker

GRAL
Trading on

Industry

Biotechnology

Employees

1,360
Website

GRAIL Metrics

BasicAdvanced
$450M
Market cap
-
P/E ratio
-$92.87
EPS
-
Beta
-
Dividend rate
$450M
$23.36
$12.33
911K
11.553
11.086
2.307
2.824
4.1
0.17
0.74
-0.665
449.89%
221.93%

GRAIL Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy GRAL

$

Sign up or log in to buy
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for GRAIL stock?

GRAIL (GRAL) has a market cap of $450M as of October 14, 2024.

What is the P/E ratio for GRAIL stock?

The price to earnings (P/E) ratio for GRAIL (GRAL) stock is 0 as of October 14, 2024.

Does GRAIL stock pay dividends?

No, GRAIL (GRAL) stock does not pay dividends to its shareholders as of October 14, 2024.

When is the next GRAIL dividend payment date?

GRAIL (GRAL) stock does not pay dividends to its shareholders.

What is the beta indicator for GRAIL?

GRAIL (GRAL) does not currently have a Beta indicator.